Back to Peptide Library
Longevity Research Peptide

Epitalon

Also called Epithalon • Pineal Tetrapeptide

Epitalon is a synthetic four-amino-acid peptide studied for possible effects on telomerase activity, pineal signaling, sleep, retinal health, oxidative stress, and longevity. Most evidence comes from cell studies, animal models, and older Russian clinical literature rather than modern large randomized trials.

Telomere Research Sleep & Circadian Rhythm Retinal Research Pineal Signaling
Protocol Snapshot

Epitalon Quick Reference

Verified Vendors
Epitalon
Peptide Protocols Epitalon product
Compare Verified Vendors
  • Current price and availability
  • Price per mg and vial-size comparison
  • Testing and fulfillment details
Compare
View Price Index
Community Dose
500mcg–1mg
Once daily, typically in the evening.
Cycle Length
10–20 days
Commonly repeated 2–3 times per year.
Class
Pineal Peptide
Review the full protocol details below.
Primary Use
Longevity
Review the full protocol details below.
Peptide Grade
GradeB
Promising longevity and circadian-rhythm research is reinforced by strong community reports of sleep-cycle improvement, sometimes after the first dose. Limited human evidence and long-term safety data constrain the grade.
Research Community Safety
Foundation

Research context, mechanisms, and practical use cases

What is Epitalon?

Epitalon—also spelled Epithalon—is a synthetic tetrapeptide made from alanine, glutamic acid, aspartic acid, and glycine. It was developed from research on Epithalamin, a pineal-gland peptide extract studied by Professor Vladimir Khavinson and colleagues in Russia.

Telomeres are protective DNA-protein structures at the ends of chromosomes. They are often compared to the plastic tips on shoelaces because they help keep chromosome ends from fraying. Telomeres generally shorten as cells divide, and critically short telomeres can contribute to cellular senescence or cell death.

Telomerase is an enzyme capable of adding telomeric DNA back to chromosome ends. In most adult somatic cells, telomerase activity is low or absent. Laboratory studies have reported that Epitalon can increase telomerase activity and extend telomeres in cultured human cells, but that has not yet established a proven anti-aging effect in living humans.

Epitalon has also been investigated for possible effects on pineal signaling and melatonin production. This is the basis for its use in sleep and circadian-rhythm protocols, although the strength of the human evidence is limited.

Why the Evidence Needs Careful Framing

Epitalon has intriguing cell, animal, and small clinical findings, but claims that it reverses aging, repairs telomeres in humans, or extends human lifespan are not established. Much of the clinical literature is older, difficult to independently verify, or based on Epithalamin rather than purified synthetic Epitalon.

A 2017 analysis reportedly detected the Ala-Glu-Asp-Gly sequence in pineal peptide material, supporting the idea that this sequence may occur naturally in pineal tissue. Epitalon itself remains an experimental compound and is not FDA approved.

Potential Epitalon Benefits

The following benefits are research targets rather than established medical outcomes. Evidence quality varies substantially by claim.

Telomere & Telomerase Research

Epitalon has increased telomerase activity and telomere length in cultured human somatic cells and human cell lines. Direct evidence that it lengthens telomeres in treated adults remains insufficient.

Sleep Quality

Older research on pineal peptide preparations reported improvements in melatonin rhythms and sleep in older adults. Users often report sleep changes early in a cycle, but purified Epitalon has not been validated as an insomnia treatment.

Lifespan Research

Some rodent studies reported improvements in survival measures, while others found no increase in mean lifespan. Animal findings do not establish human lifespan extension.

Tumor-Incidence Research

Several animal studies reported lower spontaneous tumor incidence or delayed tumor development. This does not prove cancer prevention in humans, and telomerase activation creates unresolved theoretical concerns in people with malignancy.

Antioxidant Protection

Animal and laboratory studies suggest Epitalon may influence antioxidant enzymes, mitochondrial activity, and oxidative-stress markers. Clinical significance remains uncertain.

Retinal Health

A published report on degenerative retinal disease described positive clinical effects in approximately 90% of treated cases. The report provides limited methodological detail and has not been confirmed in large modern trials.

Protocol Planning

Dosing, cycling, and preparation

Epitalon Dosing Protocol

This is a community-use protocol for synthetic Epitalon, not an FDA-approved regimen or a modern dose-finding protocol. Older milligram-heavy schedules may reflect Epithalamin extract research rather than purified Epitalon.

Community Protocol

Dose
500mcg to 1mg daily
Frequency
Once daily
Timing
Evening, based on its proposed pineal and melatonin effects
Route
Subcutaneous injection
Duration
10–20 consecutive days

Cycle Schedule

Cycles
2–3 times per year
Spacing
Several months between cycles
Continuous Use
Not recommended as a default community approach
Evidence Note
Claims that continuous dosing provides no added benefit are not supported by strong modern comparative trials.

Epitalon Reconstitution

The following example uses a 10mg vial with 2mL of bacteriostatic water.

10mg Vial

Vial Size
10mg
BAC Water
2mL
Concentration
5mg/mL
500mcg
10 units on a U-100 insulin syringe
1mg
20 units on a U-100 insulin syringe
Reconstitution Calculator

Handling Notes

Mixing
Add bacteriostatic water to the vial.
Do Not
Do not shake aggressively.
Storage
Refrigerate after reconstitution.
Anecdotal Data Points

Community-reported outcomes and recurring patterns

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

  • Improved sleep quality is the most consistently reported effect, including deeper sleep and easier sleep onset.
  • Many users report unusually vivid dreams, particularly during the first week of a cycle.
  • Some users report improved recovery from training, though this is less consistent than the sleep reports.
  • Some users describe better daytime energy, possibly as a downstream effect of better sleep rather than a direct action.
  • Dosing confusion is common because older 5–10mg schedules are frequently attributed to Epithalamin extract protocols rather than purified synthetic Epitalon.

Negative Reports

  • Most community users report few major side effects at microgram-to-low-milligram doses, with injection-site irritation and mild headache reported most often.
Stacking & Synergy

Potential Epitalon pairings and tracking context

Epitalon Stacking & Synergy

Epitalon + SS-31 + FOXO4-DRI

This is discussed in longevity communities as a multi-pathway stack targeting telomere biology, mitochondrial function, and cellular senescence. FOXO4-DRI remains highly experimental, and no human trial has established the safety or effectiveness of combining these compounds.

Transition to MOTS-c + NAD+

Some users transition from an SS-31 phase to MOTS-c and NAD+ support. This is a speculative sequencing strategy rather than a validated longevity protocol.

Epitalon + NAD+

This pairing is intended to target different aspects of cellular aging: telomere-related pathways with Epitalon and energy metabolism or DNA-repair support with NAD+. No controlled human combination data exists.

Epitalon + Pinealon

This Khavinson-style pairing targets complementary aging pathways: Epitalon for pineal signaling, circadian rhythm, and telomere-related research; Pinealon for neuronal stress resistance and cognitive support. Both peptides showed antihypoxic activity when evaluated in the same animal study, but they were not tested as a combined treatment. The pairing remains a community strategy rather than a validated synergy.

These combinations are speculative and should not be described as proven anti-aging regimens. FOXO4-DRI has especially limited human safety data.
Free with login

Track in Journal

Track Epitalon with the markers that matter most for this compound.

  • Dose, route, timing, and cycle day.
  • Sleep timing, awakenings, dream intensity, and morning restfulness.
  • Daytime energy, mood, and any injection-site or sleep disruption.
Safety Notes

Side effects, contraindications, and precautions

Epitalon Side Effects

Published reports often describe Epitalon or related pineal peptide preparations as well tolerated, but formal modern safety characterization is limited. Long-term risk, dose-response, immunogenicity, product purity, and cancer-related concerns remain incompletely defined.

A favorable signal in small or older studies does not establish long-term safety. FDA has specifically noted that it lacks sufficient safety information for compounded Epitalon and has raised concerns about aggregation, immunogenicity, and peptide-related impurities.
Common / Mild Reports
  • Injection-site redness, swelling, or mild discomfort.
  • Vivid dreams.
  • Temporary changes in sleep patterns during the first several days.
Uncommon / Less Common Reports
  • Mild headache.
  • Temporary fatigue during initial use.
  • Drowsiness, especially early in a cycle.

Epitalon Contraindications and Precautions

Do Not Use If You Have

  • Active cancer or an active tumor, because telomerase activation raises unresolved theoretical concerns in humans.
  • A history of malignancy unless your oncologist specifically approves use.
  • Known hypersensitivity to Epitalon or any formulation component.

Use Caution With

  • Pregnancy or breastfeeding, because no safety data exists.
  • Autoimmune conditions, due to limited human safety information.
  • Any serious condition requiring ongoing medical supervision.

Drug Interactions

No well-established interaction profile exists. Combining Epitalon with exogenous melatonin or sedating sleep products could theoretically increase sleepiness if Epitalon alters endogenous melatonin signaling.

Regulatory Status

Epitalon is not FDA approved for any indication. It previously received an orphan-drug designation for retinitis pigmentosa, but that designation was withdrawn or revoked and did not result in FDA approval. FDA also lists compounded Epitalon among substances that may present significant safety risks because of insufficient human safety information and potential peptide-quality concerns.

FINAL VERDICT

Peptide Protocol's Opinionated Opinion

This is not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.

Epitalon might be one of our favorite peptides. It doesn’t have a large following and won’t show up on many popularity lists, but in our research experiment it was one of the fastest-working and most effective peptides we’ve used.

Most people know Epitalon as the longevity peptide and associate that with potentially lengthening telomeres. In the real world, however, the more compelling anecdote is circadian-rhythm correction—which may then contribute to the longevity angle.

The only thing keeping it from an A grade is the limited human data and lack of a conclusive safety profile.